Announcement on Pledge of Shares by the Controlling Shareholder of Dashenlin Pharmaceutical Group Co., Ltd.
Announcement on the Progress of Stock Repurchase by Dashenlin Pharmaceutical Group Co., Ltd.
Announcement on Pledge of Shares by the Controlling Shareholder of Dashenlin Pharmaceutical Group Co., Ltd.
Announcement on Pledge of Shares by the Controlling Shareholder of Dashenlin Pharmaceutical Group Co., Ltd.
Announcement on Pledge of Shares by the Controlling Shareholder of Dashenlin Pharmaceutical Group Co., Ltd.
Announcement on Pledge of Shares by the Controlling Shareholder of Dashenlin Pharmaceutical Group Co., Ltd.
Announcement on the Progress of Share Repurchase by Dashenlin Pharmaceutical Group Co., Ltd.
Announcement on Pledge of Shares by the Controlling Shareholder of Dashenlin Pharmaceutical Group Co., Ltd.
Announcement of Implementation of Equity Distribution for Dashenlin Pharmaceutical Group Co., Ltd. in 2023.
An indicative announcement of Dashenlin Pharmaceutical Group Co., Ltd. on the progress of repurchase and distribution of rights
Announcement of Dashenlin Pharmaceutical Group Co., Ltd. on the first repurchase of the company's shares and progress through centralized bidding
Announcement of Dashenlin Pharmaceutical Group Co., Ltd. on the 2023 profit distribution plan
Report of Dashenlin Pharmaceutical Group Co., Ltd. on the repurchase of the company's shares through centralized bidding transactions
Announcement of Dashenlin Pharmaceutical Group Co., Ltd. on the shareholding status of the top ten shareholders and the top ten shareholders with unlimited sales conditions in the share repurchase matter
Announcement of Dashenlin Pharmaceutical Group Co., Ltd. on the plan to repurchase shares through centralized bidding
Announcement of Dashenlin Pharmaceutical Group Co., Ltd. on the implementation of share incentive restricted stock repurchase and cancellation
Dashenlin Pharmaceutical Group Co., Ltd.'s indicative announcement on the chairman's proposal to repurchase the company's shares
Announcement of Dashenlin Pharmaceutical Group Co., Ltd. on the cancellation of the pledge of some of the controlling shareholder\'s shares
Announcement of Dashenlin Pharmaceutical Group Co., Ltd. on receipt of the Shanghai Stock Exchange\'s “Decision to Terminate the Review of Issuance of Shares by Dashenlin Pharmaceutical Group Co., Ltd. to Specific Targets”
Announcement of Dashenlin Pharmaceutical Group Co., Ltd. on the company\'s controlling shareholder\'s share pledge
No Data